Section 11 PE Tables – Results from the 2019 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

200406

Table 11.1A – Settings Where Mental Health Services Were Received in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2019
Setting Where Mental Health Service Was Received	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
SPECIALTY MENTAL HEALTH SERVICE¹	2,898^a	3,065^a	3,348^a	3,362^a	3,255^a	3,104^a	3,129^a	2,925^a	2,920^a	3,101^a	3,118^a	3,341^a	3,369^a	3,253^a	3,598^a	3,646^a	3,901	4,088
Outpatient	2,662^a	2,795^a	3,015^a	3,048^a	2,931^a	2,787^a	2,837^a	2,650^a	2,635^a	2,842^a	2,846^a	3,064^a	3,110^a	2,958^a	3,239^a	3,328^a	3,547	3,747
Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor	2,254^a	2,347^a	2,523^a	2,573^a	2,416^a	2,365^a	2,408^a	2,296^a	2,265^a	2,409^a	2,427^a	2,572^a	2,698^a	2,532^a	2,819^a	2,908^a	3,080	3,213
Mental Health Clinic or Center	611^a	635^a	716^a	657^a	587^a	583^a	567^a	537^a	547^a	547^a	610^a	731^a	760^a	792^a	929^a	995^a	977^a	1,169
Partial Day Hospital or Day Treatment Program	440	425^a	439	449	471	416^a	374^a	340^a	362^a	393^a	431^a	477	467	455	489	505	484	517
In-Home Therapist, Counselor, or Family Preservation Worker	693^a	656^a	762^a	731^a	719^a	707^a	716^a	657^a	674^a	767^a	776^a	787^a	836^a	830^a	845^a	840^a	951^a	1,091
Inpatient or Residential¹	509^a	542^a	629	619	596^a	581^a	539^a	524^a	531^a	526^a	547^a	574^a	606	642	737	708	683	701
Hospital	422^a	467^a	515^a	529	516^a	511^a	469^a	440^a	447^a	438^a	463^a	504^a	547	588	666	622	608	618
Residential Treatment Center	224^a	233	299	229	225^a	199^a	198^a	213^a	217^a	240	238	206^a	252	271	311	318	300	293
NONSPECIALTY MENTAL HEALTH SERVICE²	nc	nc	nc	nc	nc	nc	nc	3,430^a	3,465^a	3,463^a	3,649^a	3,634^a	3,736^a	3,691^a	3,732^a	3,810^a	3,977^a	4,371
Education^2,3	nc	nc	nc	nc	nc	nc	nc	2,931^a	2,957^a	2,920^a	3,157^a	3,147^a	3,229^a	3,206^a	3,193^a	3,231^a	3,444^a	3,727
School Social Worker, School Psychologist, or School Counselor	nc	nc	nc	nc	nc	nc	nc	2,286^a	2,214^a	2,188^a	2,389^a	2,284^a	2,379^a	2,239^a	2,278^a	2,249^a	2,395^a	2,698
Special School or Program within a Regular School for Students with Emotional or Behavioral Problems	nc	nc	nc	nc	nc	nc	nc	975^a	1,054^a	1,063^a	1,142^a	1,218^a	1,207^a	1,357	1,319	1,345	1,461	1,477
General Medicine
Pediatrician or Other Family Doctor	657^a	732^a	840	810	694^a	692^a	710^a	605^a	601^a	619^a	629^a	686^a	700^a	668^a	708^a	805	767^a	902
Juvenile Justice
Juvenile Detention Center, Prison, or Jail	--	--	--	--	--	--	--	109^a	80	103^a	83^a	59	63	53	53	45	48	49
Child Welfare
Foster Care or Therapeutic Foster Care	157^a	179^a	158^a	143	129	114	118	92	108	140	96	99	92	79	108	92	94	97
SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES^1,2,3	nc	nc	nc	nc	nc	nc	nc	1,226^a	1,283^a	1,328^a	1,397^a	1,490^a	1,457^a	1,408^a	1,513^a	1,615^a	1,706^a	1,910
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH. ² Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH. ³ Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this setting. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019.

200406

Table 11.1B – Settings Where Mental Health Services Were Received in Past Year among Persons Aged 12 to 17: Percentages, 2002-2019
Setting Where Mental Health Service Was Received	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
SPECIALTY MENTAL HEALTH SERVICE¹	11.8^a	12.4^a	13.4^a	13.4^a	13.0^a	12.4^a	12.7^a	12.0^a	12.1^a	12.6^a	12.7^a	13.6^a	13.7^a	13.3^a	14.7^a	14.8^a	16.0	16.7
Outpatient	10.8^a	11.3^a	12.1^a	12.1^a	11.7^a	11.2^a	11.5^a	10.9^a	10.9^a	11.5^a	11.5^a	12.5^a	12.7^a	12.0^a	13.2^a	13.6^a	14.5	15.3
Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor	9.2^a	9.5^a	10.1^a	10.2^a	9.6^a	9.5^a	9.8^a	9.4^a	9.4^a	9.8^a	9.8^a	10.5^a	11.0^a	10.3^a	11.5^a	11.8^a	12.6	13.1
Mental Health Clinic or Center	2.5^a	2.6^a	2.9^a	2.6^a	2.3^a	2.3^a	2.3^a	2.2^a	2.3^a	2.2^a	2.5^a	3.0^a	3.1^a	3.2^a	3.8^a	4.0^a	4.0^a	4.8
Partial Day Hospital or Day Treatment Program	1.8	1.7^a	1.8^a	1.8	1.9	1.7^a	1.5^a	1.4^a	1.5^a	1.6^a	1.7^a	1.9	1.9	1.8	2.0	2.0	2.0	2.1
In-Home Therapist, Counselor, or Family Preservation Worker	2.8^a	2.6^a	3.0^a	2.9^a	2.9^a	2.8^a	2.9^a	2.7^a	2.8^a	3.1^a	3.1^a	3.2^a	3.4^a	3.4^a	3.4^a	3.4^a	3.9^a	4.5
Inpatient or Residential¹	2.1^a	2.2^a	2.5	2.5	2.4^a	2.3^a	2.2^a	2.1^a	2.2^a	2.1^a	2.2^a	2.3^a	2.5	2.6	3.0	2.9	2.8	2.9
Hospital	1.7^a	1.9^a	2.1^a	2.1^a	2.0^a	2.0^a	1.9^a	1.8^a	1.8^a	1.8^a	1.9^a	2.0^a	2.2	2.4	2.7	2.5	2.5	2.5
Residential Treatment Center	0.9^a	0.9	1.2	0.9^a	0.9^a	0.8^a	0.8^a	0.9^a	0.9^a	1.0	1.0	0.8^a	1.0	1.1	1.3	1.3	1.2	1.2
NONSPECIALTY MENTAL HEALTH SERVICE²	nc	nc	nc	nc	nc	nc	nc	14.2^a	14.5^a	14.2^a	15.0^a	15.0^a	15.4^a	15.2^a	15.4^a	15.7^a	16.5^a	18.1
Education^2,3	nc	nc	nc	nc	nc	nc	nc	12.1^a	12.4^a	11.9^a	12.9^a	13.0^a	13.2^a	13.2^a	13.1^a	13.3^a	14.2^a	15.4
School Social Worker, School Psychologist, or School Counselor	nc	nc	nc	nc	nc	nc	nc	9.4^a	9.2^a	8.9^a	9.7^a	9.4^a	9.7^a	9.2^a	9.3^a	9.2^a	9.9^a	11.1
Special School or Program within a Regular School for Students with Emotional or Behavioral Problems	nc	nc	nc	nc	nc	nc	nc	4.0^a	4.4^a	4.3^a	4.7^a	5.0^a	4.9^a	5.6	5.4	5.5	6.0	6.1
General Medicine
Pediatrician or Other Family Doctor	2.7^a	2.9^a	3.4	3.2	2.8^a	2.8^a	2.9^a	2.5^a	2.5^a	2.5^a	2.5^a	2.8^a	2.9^a	2.7^a	2.9^a	3.3	3.1^a	3.7
Juvenile Justice
Juvenile Detention Center, Prison, or Jail	--	--	--	--	--	--	--	0.4^a	0.3^a	0.4^a	0.3^a	0.2	0.3	0.2	0.2	0.2	0.2	0.2
Child Welfare
Foster Care or Therapeutic Foster Care	0.6^a	0.7^a	0.6^a	0.6	0.5	0.5	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4
SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES^1,2,3	nc	nc	nc	nc	nc	nc	nc	5.0^a	5.3^a	5.4^a	5.7^a	6.1^a	5.9^a	5.7^a	6.2^a	6.6^a	7.0^a	7.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH. ² Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH. ³ Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this setting. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019.

200406

Table 11.2A – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2004-2019
Demographic Characteristic	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	2,225^a	2,191^a	1,970^a	2,016^a	2,027^a	1,954^a	1,911^a	2,011^a	2,213^a	2,587^a	2,751^a	3,031^a	3,089^a	3,214^a	3,482^a	3,783
AGE GROUP
12-13	445^a	417^a	383^a	337^a	366^a	330^a	330^a	312^a	420^a	470^a	548^a	587^a	548^a	516^a	632^a	816
14-15	783^a	811^a	684^a	705^a	706^a	741^a	706^a	710^a	844^a	1,025^a	986^a	1,163^a	1,115^a	1,200	1,250	1,341
16-17	997^a	964^a	902^a	974^a	955^a	883^a	876^a	989^a	950^a	1,091^a	1,217^a	1,281^a	1,427^a	1,498	1,600	1,626
GENDER
Male	637^a	571^a	539^a	586^a	540^a	577^a	536^a	566^a	581^a	657^a	710^a	725^a	786^a	845^a	946^a	1,076
Female	1,588^a	1,620^a	1,431^a	1,430^a	1,487^a	1,377^a	1,375^a	1,446^a	1,632^a	1,930^a	2,042^a	2,306^a	2,303^a	2,369^a	2,537	2,708
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,848^a	1,802^a	1,614^a	1,691^a	1,681^a	1,594^a	1,537^a	1,586^a	1,648^a	1,970^a	2,123^a	2,323^a	2,366^a	2,419^a	2,601	2,755
White	1,413^a	1,390^a	1,220^a	1,284^a	1,266^a	1,180^a	1,186^a	1,167^a	1,231^a	1,449^a	1,578^a	1,742^a	1,781^a	1,785	1,905	1,975
Black or African American	287^a	288	245^a	292	261^a	285^a	236^a	238^a	269^a	289^a	306	302	301	313	334	367
AIAN	13	10	12	7^a	13	9	10^a	15	7^a	7^a	11	*	16	24	23	20
NHOPI	*	*	*	*	*	*	1	*	*	*	*	*	*	*	*	*
Asian	82^a	63^a	77^a	66^a	73^a	73^a	57^a	90^a	49^a	123	124	118^a	152	145	189	190
Two or More Races	51^a	41^a	52^a	41^a	59^a	41^a	48^a	75^a	81^a	95^a	93^a	121^a	109^a	138^a	137^a	189
Hispanic or Latino	377^a	389^a	356^a	325^a	347^a	360^a	374^a	425^a	566^a	617^a	628^a	708^a	724^a	795^a	882^a	1,028
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.2B – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2004-2019
Demographic Characteristic	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	9.0^a	8.8^a	7.9^a	8.2^a	8.3^a	8.1^a	8.0^a	8.2^a	9.1^a	10.7^a	11.4^a	12.5^a	12.8^a	13.3^a	14.4^a	15.7
AGE GROUP
12-13	5.4^a	5.2^a	4.9^a	4.3^a	4.9^a	4.6^a	4.3^a	4.1^a	5.4^a	6.1^a	7.2^a	7.8^a	7.3^a	6.9^a	8.4^a	10.5
14-15	9.2^a	9.5^a	7.9^a	8.4^a	8.5^a	8.8^a	9.0^a	8.6^a	10.2^a	12.4^a	11.9^a	13.8^a	13.3^a	14.5^a	15.3	16.4
16-17	12.3^a	11.5^a	10.7^a	11.5^a	11.2^a	10.4^a	10.6^a	11.7^a	11.4^a	13.2^a	14.6^a	15.5^a	17.2^a	17.7^a	19.0	20.1
GENDER
Male	5.0^a	4.5^a	4.2^a	4.6^a	4.3^a	4.7^a	4.4^a	4.5^a	4.7^a	5.3^a	5.7^a	5.8^a	6.4^a	6.8^a	7.7^a	8.8
Female	13.1^a	13.3^a	11.8^a	11.9^a	12.5^a	11.7^a	11.9^a	12.1^a	13.7^a	16.2^a	17.3^a	19.5^a	19.4^a	20.0^a	21.5	23.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.9^a	8.7^a	7.9^a	8.4^a	8.5^a	8.2^a	8.1^a	8.3^a	8.7^a	10.4^a	11.3^a	12.5^a	12.8^a	13.1^a	14.2	15.2
White	9.2^a	9.1^a	8.2^a	8.7^a	8.8^a	8.4^a	8.6^a	8.6^a	9.1^a	10.9^a	12.0^a	13.4^a	13.8^a	14.0^a	15.1	15.9
Black or African American	7.7^a	7.6^a	6.4^a	7.8^a	7.1^a	7.9^a	6.8^a	7.0^a	7.9^a	8.6^a	9.1^a	9.0^a	9.1^a	9.5	10.3	11.4
AIAN	7.8	6.1	9.3	4.6^a	10.1	7.5	7.4	11.4	5.2	4.5^a	6.9	*	11.5	16.3	15.2	12.2
NHOPI	*	*	*	*	*	*	1.8	*	*	*	*	*	*	*	*	*
Asian	8.3^a	6.0^a	7.7^a	6.6^a	7.7^a	7.6^a	5.5^a	7.6^a	4.2^a	10.2	10.4	9.7^a	11.9	11.3	13.6	15.1
Two or More Races	11.7^a	10.5^a	13.0^a	9.9^a	12.0^a	8.0^a	9.4^a	10.6^a	11.3^a	13.0^a	12.5^a	15.6^a	13.8^a	16.9	17.7	20.9
Hispanic or Latino	9.1^a	9.1^a	8.0^a	7.1^a	7.5^a	7.7^a	7.8^a	8.1^a	10.5^a	11.4^a	11.5^a	12.6^a	12.7^a	13.8^a	15.1	17.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.3A – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2006-2019
Demographic Characteristic	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	1,358^a	1,371^a	1,460^a	1,404^a	1,350^a	1,388^a	1,544^a	1,868^a	1,990^a	2,129^a	2,168^a	2,265^a	2,423^a	2,671
AGE GROUP
12-13	211^a	200^a	239^a	235^a	232^a	218^a	285^a	314^a	375^a	388^a	354^a	332^a	382^a	530
14-15	518^a	500^a	505^a	521^a	479^a	487^a	590^a	752^a	707^a	826^a	789^a	861	891	970
16-17	629^a	671^a	716^a	648^a	639^a	683^a	669^a	801^a	909^a	915^a	1,025^a	1,072	1,150	1,171
GENDER
Male	335^a	386^a	359^a	391^a	395^a	397^a	373^a	435^a	461^a	477^a	539^a	581^a	628^a	736
Female	1,023^a	986^a	1,101^a	1,013^a	954^a	991^a	1,172^a	1,432^a	1,529^a	1,652^a	1,629^a	1,684^a	1,795	1,935
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,118^a	1,141^a	1,226^a	1,150^a	1,093^a	1,113^a	1,152^a	1,425^a	1,540^a	1,651^a	1,703^a	1,694^a	1,841	1,981
White	871^a	873^a	944^a	858^a	853^a	799^a	883^a	1,046^a	1,167^a	1,258^a	1,290	1,256	1,354	1,415
Black or African American	150^a	193^a	171^a	204	157^a	183^a	164^a	207	214	198	196	233	225	256
AIAN	9	4^a	8	5^a	7^a	13	4^a	6^a	8^a	*	8	6^a	*	19
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	54^a	39^a	44^a	48^a	44^a	60^a	30^a	98	80^a	67^a	118	101	127	142
Two or More Races	32^a	32^a	50^a	31^a	30^a	57^a	64^a	61^a	66^a	98	86^a	89^a	109	134
Hispanic or Latino	240^a	230^a	233^a	254^a	257^a	275^a	392^a	442^a	450^a	477^a	465^a	571^a	582	690
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.3B – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2006-2019
Demographic Characteristic	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	5.5^a	5.5^a	6.0^a	5.8^a	5.7^a	5.7^a	6.3^a	7.7^a	8.2^a	8.8^a	9.0^a	9.4^a	10.0^a	11.1
AGE GROUP
12-13	2.7^a	2.5^a	3.2^a	3.2^a	3.0^a	2.8^a	3.7^a	4.1^a	4.9^a	5.1^a	4.7^a	4.4^a	5.1^a	6.8
14-15	6.0^a	6.0^a	6.1^a	6.2^a	6.1^a	5.9^a	7.1^a	9.1^a	8.5^a	9.8^a	9.4^a	10.4	10.9	11.9
16-17	7.5^a	7.9^a	8.4^a	7.7^a	7.7^a	8.1^a	8.0^a	9.7^a	10.9^a	11.1^a	12.4^a	12.7^a	13.7	14.5
GENDER
Male	2.6^a	3.0^a	2.9^a	3.2^a	3.2^a	3.2^a	3.0^a	3.5^a	3.7^a	3.8^a	4.4^a	4.7^a	5.1^a	6.0
Female	8.4^a	8.2^a	9.3^a	8.6^a	8.2^a	8.3^a	9.8^a	12.0^a	13.0^a	14.0^a	13.7^a	14.2^a	15.2	16.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.5^a	5.7^a	6.2^a	5.9^a	5.7^a	5.8^a	6.1^a	7.6^a	8.2^a	8.9^a	9.2^a	9.2^a	10.1	11.0
White	5.8^a	5.9^a	6.5^a	6.1^a	6.2^a	5.9^a	6.5^a	7.8^a	8.9^a	9.7^a	10.0^a	9.8^a	10.7	11.4
Black or African American	3.9^a	5.1^a	4.6^a	5.7^a	4.5^a	5.4^a	4.8^a	6.2	6.4	5.9^a	6.0^a	7.1	6.9	8.0
AIAN	6.6	2.6^a	6.5	4.3^a	5.4	9.8	2.6^a	3.8^a	4.9	*	5.7	3.9^a	*	11.5
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	5.3^a	3.9^a	4.7^a	5.0^a	4.3^a	5.0^a	2.6^a	8.1	6.6^a	5.5^a	9.3	7.9	9.2	11.3
Two or More Races	8.0^a	7.8^a	10.2	6.0^a	5.9^a	8.1^a	9.0^a	8.4^a	8.9^a	12.6	10.9	10.9	14.2	14.9
Hispanic or Latino	5.4^a	5.1^a	5.1^a	5.4^a	5.4^a	5.2^a	7.3^a	8.2^a	8.2^a	8.5^a	8.2^a	9.9	10.0	11.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.4A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode in Past Year, by Demographic Characteristics: Numbers in Thousands, 2004-2019
Demographic Characteristic	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	895^a	822^a	760^a	782^a	764^a	673^a	721^a	769^a	813^a	977^a	1,122^a	1,186^a	1,249^a	1,330^a	1,432^a	1,627
AGE GROUP
12-13	169^a	136^a	133^a	137^a	122^a	98^a	106^a	112^a	127^a	181^a	194^a	185^a	189^a	193^a	251	302
14-15	278^a	329^a	263^a	259^a	236^a	244^a	271^a	258^a	307^a	376^a	394^a	472^a	455^a	453^a	514	585
16-17	448^a	357^a	364^a	386^a	405^a	331^a	343^a	400^a	379^a	420^a	535^a	530^a	605^a	684	667	740
GENDER
Male	239^a	193^a	189^a	214^a	183^a	168^a	171^a	199^a	163^a	193^a	265^a	262^a	260^a	274^a	351	391
Female	656^a	629^a	571^a	568^a	581^a	505^a	549^a	570^a	650^a	784^a	857^a	924^a	989^a	1,056^a	1,081^a	1,236
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	756^a	700^a	634^a	691^a	658^a	555^a	577^a	645^a	642^a	753^a	918^a	936^a	1,008^a	1,072^a	1,100^a	1,251
White	633^a	544^a	502^a	545^a	545^a	444^a	487^a	482^a	500^a	598^a	723^a	702^a	799^a	847^a	870	985
Black or African American	82^a	113	70^a	116	85^a	67^a	54^a	97	90	83^a	123	127	102	110	115	130
AIAN	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Two or More Races	*	*	*	*	*	*	*	*	*	*	*	55	*	62	48^a	83
Hispanic or Latino	139^a	122^a	126^a	91^a	105^a	118^a	144^a	125^a	171^a	224^a	204^a	251^a	241^a	258^a	332	376
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.4B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode in Past Year, by Demographic Characteristics: Percentages, 2004-2019
Demographic Characteristic	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	40.3	37.8^a	38.8^a	39.0^a	37.7^a	34.6^a	37.8^a	38.4^a	37.0^a	38.1^a	41.2	39.3^a	40.9	41.5	41.4	43.3
AGE GROUP
12-13	38.2	32.9	35.1	41.5	33.5	30.0	32.5	36.3	30.7	39.1	35.9	31.9	35.3	37.6	40.7	37.5
14-15	35.5^a	41.1	38.4	36.8^a	33.6^a	33.2^a	38.4	36.3^a	36.6^a	37.2^a	40.1	40.6	41.3	37.9	41.2	43.9
16-17	45.0	37.1^a	40.7	39.8^a	42.4	37.5^a	39.3^a	40.5	40.0	38.6^a	44.4	41.5	42.6	45.8	41.8	45.6
GENDER
Male	37.7	34.1	35.3	36.7	34.0	29.2^a	32.0	35.3	28.3^a	29.7	37.7	36.3	33.5	32.5	37.5	36.8
Female	41.3	39.0^a	40.2^a	40.0^a	39.1^a	36.9^a	40.1^a	39.5^a	40.1^a	40.9^a	42.4	40.3^a	43.4	44.8	42.9	45.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	41.0^a	39.0^a	39.5^a	41.1^a	39.3^a	35.0^a	37.6^a	40.7^a	39.0^a	38.5^a	43.5	40.5^a	42.9	44.4	42.6	45.7
White	44.9^a	39.3^a	41.3^a	42.7^a	43.1^a	37.7^a	41.1^a	41.4^a	40.7^a	41.6^a	46.1	40.6^a	45.1^a	47.5	46.1	50.3
Black or African American	28.9	39.3	29.1	39.7	32.4	23.9^a	23.0^a	41.0	33.5	28.6	40.6	42.0	34.5	35.1	34.6	35.6
AIAN	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Two or More Races	*	*	*	*	*	*	*	*	*	*	*	46.7	*	44.8	34.8	44.4
Hispanic or Latino	36.8	31.8	35.9	28.2	30.4	33.0	38.4	29.4	30.8	36.9	33.1	35.5	34.1	32.7	37.9	36.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.5A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year, by Demographic Characteristics: Numbers in Thousands, 2006-2019
Demographic Characteristic	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	627^a	601^a	622^a	542^a	554^a	602^a	633^a	832^a	882^a	945^a	1,001^a	1,074^a	1,133^a	1,321
AGE GROUP
12-13	92^a	85^a	91^a	78^a	66^a	91^a	91^a	150^a	143^a	142^a	131^a	153^a	177	218
14-15	232^a	216^a	194^a	184^a	215^a	200^a	239^a	320^a	307^a	374^a	369^a	364^a	406	492
16-17	304^a	300^a	336^a	280^a	273^a	311^a	302^a	363^a	433^a	429^a	501^a	558	550	612
GENDER
Male	134^a	154^a	132^a	132^a	132^a	147^a	127^a	157^a	189^a	206^a	208^a	208^a	274	300
Female	493^a	447^a	489^a	410^a	422^a	455^a	506^a	675^a	693^a	739^a	793^a	866^a	859^a	1,021
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	535^a	534^a	550^a	443^a	448^a	502^a	506^a	645^a	725^a	755^a	827^a	868^a	882^a	1,018
White	432^a	439^a	461^a	352^a	380^a	379^a	403^a	504^a	572^a	563^a	668^a	679^a	695	800
Black or African American	53^a	72	65^a	58^a	42^a	82	56^a	72	99	97	71	97	90	108
AIAN	*	*	*	*	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Two or More Races	*	*	*	*	*	*	*	*	*	*	*	*	*	63
Hispanic or Latino	92^a	67^a	72^a	99^a	106^a	100^a	127^a	187^a	158^a	190^a	174^a	206^a	251	304
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.5B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year, by Demographic Characteristics: Percentages, 2006-2019
Demographic Characteristic	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
TOTAL	46.5	43.9^a	42.6^a	38.8^a	41.1^a	43.5^a	41.0^a	45.0^a	44.7^a	44.6^a	46.7	47.5	46.9	49.7
AGE GROUP
12-13	44.1	42.3	38.3	33.8	28.7^a	42.3	32.0^a	48.5	38.7	37.0	37.6	46.2	47.2	41.9
14-15	44.8	43.2	38.6^a	35.6^a	45.0	41.0^a	40.5^a	43.2^a	43.4	45.4	47.5	42.3^a	45.6	50.8
16-17	48.8	44.9^a	46.9	43.2^a	42.7^a	45.5	45.4^a	45.3^a	48.1	47.1	49.2	52.0	47.8	52.3
GENDER
Male	40.1	40.2	36.9	34.0	33.4	37.3	34.4	36.4	41.2	43.1	39.0	35.8	43.7	41.2
Female	48.6	45.4^a	44.5^a	40.7^a	44.3^a	45.9^a	43.2^a	47.6^a	45.7^a	45.1^a	49.3	51.5	48.1	52.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	48.0	46.8	44.9^a	38.7^a	41.1^a	45.2^a	43.9^a	45.6^a	47.3	46.0^a	48.9	51.3	48.1	51.7
White	49.8^a	50.4^a	48.9^a	41.1^a	44.5^a	47.4^a	45.7^a	48.6^a	49.2^a	45.0^a	52.1	54.1	51.6	57.0
Black or African American	35.5	37.4	38.0	28.9	26.9^a	44.6	34.4	34.9	46.9	48.8	37.1	41.6	40.1	42.3
AIAN	*	*	*	*	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Asian	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Two or More Races	*	*	*	*	*	*	*	*	*	*	*	*	*	47.3
Hispanic or Latino	39.4	29.4^a	30.8^a	39.3	41.3	36.4	32.6^a	43.1	35.6	40.0	38.4	36.1	43.2	44.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.6A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Numbers in Thousands, 2004-2019
Substance	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	955^a	979^a	942^a	1,138	1,207
Marijuana	601^a	553^a	483^a	473^a	485^a	472^a	481^a	523^a	547^a	664^a	664^a	675^a	751^a	724^a	878	930
Cocaine	66^a	73^a	64^a	69^a	61^a	43	46	54	53	28	41	34	35	37	35	29
Crack	15	12	16	17	12	9	9	11	7	2	11	*	4	2	0	10
Heroin	9	10	11	6	9	10	10	11	11	7	12	5	3	6	3	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	129	127	145	112	147
LSD	36^a	38^a	18^a	16^a	28^a	43^a	24^a	30^a	40^a	29^a	48^a	63	41^a	72	62	99
PCP	21	16	11	8	20	12	8	12	9	6	11	2	6	12	6	7
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	45	59	47	46	60
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	193	159^a	145^a	178	235
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	14	6	14	8	10
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	370	411	369	375	355
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	236^a	283^a	210	214	158
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	166	142	158	126	184
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	117^a	168	167	168	174
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	103	149	164	153	155
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	26	43	22	34	45
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	96^a	142	154	145	149
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	236^a	285^a	212	214	158
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	563	553	515	547	595
PAST MONTH USE
Alcohol	632	606	523^a	553	509^a	473^a	460^a	482^a	503^a	490^a	556	524^a	508^a	524^a	558	638
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	288	268	293	295	338
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	51	52	39	22^a	53
Cigarette Use	508^a	450^a	378^a	388^a	354^a	336^a	302^a	317^a	284^a	288^a	254^a	241^a	239^a	214	212	166
Daily Cigarette Use	171^a	116^a	102^a	96^a	75^a	70^a	59^a	81^a	61^a	46^a	45^a	55^a	27	25	23	14
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.6B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Percentages, 2004-2019
Substance	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	31.5	31.7	29.3	32.7	31.9
Marijuana	27.0	25.2	24.5	23.5	23.9	24.2	25.2	26.0	24.7	25.7	24.1	22.3	24.3	22.5	25.2	24.6
Cocaine	3.0^a	3.4^a	3.3^a	3.4^a	3.0^a	2.2^a	2.4^a	2.7^a	2.4^a	1.1	1.5	1.1	1.1	1.1	1.0	0.8
Crack	0.7	0.6	0.8	0.9	0.6	0.5	0.5	0.5	0.3	0.1	0.4	*	0.1	0.1	0.0	0.3
Heroin	0.4	0.4	0.5	0.3	0.4	0.5	0.5	0.5	0.5	0.3	0.4	0.2	0.1	0.2	0.1	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	4.2	4.1	4.5	3.2	3.9
LSD	1.6	1.7	0.9^a	0.8^a	1.4^a	2.2	1.2^a	1.5^a	1.8	1.1^a	1.8	2.1	1.3^a	2.2	1.8	2.6
PCP	0.9^a	0.7^a	0.6	0.4	1.0^a	0.6	0.4	0.6	0.4	0.2	0.4	0.1	0.2	0.4	0.2	0.2
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.5	1.9	1.5	1.3	1.6
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	6.4	5.1	4.5^a	5.1	6.2
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.5	0.2	0.4	0.2	0.3
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	12.2^a	13.3^a	11.5	10.8	9.4
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	7.8^a	9.2^a	6.5^a	6.1^a	4.2
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	5.5	4.6	4.9	3.6	4.9
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.9	5.5	5.2	4.8	4.6
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.4	4.8	5.1	4.4	4.1
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.8	1.4	0.7	1.0	1.2
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.2	4.6	4.8	4.2	3.9
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	7.8^a	9.2^a	6.6^a	6.1^a	4.2
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	18.6^a	17.9	16.0	15.7	15.7
PAST MONTH USE
Alcohol	28.4^a	27.6^a	26.6^a	27.4^a	25.1^a	24.2^a	24.0^a	23.9^a	22.7^a	18.9	20.2^a	17.3	16.5	16.3	16.0	16.9
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	9.5	8.7	9.1	8.5	8.9
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.7	1.7	1.2	0.6^a	1.4
Cigarette Use	22.8^a	20.5^a	19.2^a	19.2^a	17.4^a	17.2^a	15.8^a	15.8^a	12.8^a	11.1^a	9.2^a	8.0^a	7.8^a	6.7^a	6.1^a	4.4
Daily Cigarette Use	7.7^a	5.3^a	5.2^a	4.8^a	3.7^a	3.6^a	3.1^a	4.0^a	2.7^a	1.8^a	1.6^a	1.8^a	0.9^a	0.8	0.7	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.7A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year: Numbers in Thousands, 2006-2019
Substance	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	774^a	757^a	720^a	885	932
Marijuana	362^a	339^a	384^a	366^a	327^a	375^a	414^a	495^a	510^a	545^a	572^a	547^a	678	718
Cocaine	47	54	48	35	35	36	45	17	32	32	30	27	27	29
Crack	10	17	5	6	7	11	7	2	6	*	4	2	0	10
Heroin	9	6	8	6	9	8	11	7	12	2	3	4	3	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	116	102	122	96	133
LSD	13^a	13^a	23^a	30^a	20^a	23^a	36^a	19^a	45	56	31^a	58	52	87
PCP	10	5	16	6	4	7	8	6	11	2	6	11	6	7
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	43	46	42	42	56
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	151	124^a	119^a	145	178
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	10	5	14	6	10
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	325	349	285	301	301
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	201^a	237^a	170	172	136
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	148	130	122	106	157
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	103	148	131	151	147
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	89	131	127	136	129
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	25	41	19	30	43
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	82	125	119	129	124
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	201^a	238^a	172	172	136
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	477	450	406	435	482
PAST MONTH USE
Alcohol	386^a	404	385^a	372^a	318^a	331^a	370^a	365^a	421	396	373^a	398	433	487
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	228	199	220	238	262
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	49	40	29	17^a	43
Cigarette Use	290^a	285^a	275^a	276^a	219^a	225^a	217^a	221^a	203^a	213^a	194^a	168	177	129
Daily Cigarette Use	83^a	75^a	56^a	55^a	46^a	58^a	44^a	32^a	40^a	50^a	19	18	17	12
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.7B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year: Percentages, 2006-2019
Substance	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	36.3	34.9	31.8	36.5	34.9
Marijuana	26.6	24.7	26.3	26.0	24.3	27.0	26.8	26.5	25.6	25.6	26.4	24.1	28.0	26.9
Cocaine	3.5^a	4.0^a	3.3^a	2.5^a	2.6^a	2.6^a	2.9^a	0.9	1.6	1.5	1.4	1.2	1.1	1.1
Crack	0.8	1.2	0.4	0.5	0.5	0.8	0.4	0.1	0.3	*	0.2	0.1	0.0	0.4
Heroin	0.6	0.5	0.6	0.4	0.6	0.6	0.7	0.4	0.6	0.1	0.1	0.2	0.1	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	5.5	4.7	5.4	4.0	5.0
LSD	0.9^a	0.9^a	1.6^a	2.1	1.5^a	1.7^a	2.3	1.0^a	2.2	2.6	1.4^a	2.6	2.1	3.3
PCP	0.8	0.4	1.1^a	0.4	0.3	0.5	0.5	0.3	0.5	0.1	0.3	0.5	0.2	0.3
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	2.0	2.1	1.9	1.7	2.1
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	7.1	5.7	5.2	6.0	6.7
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.5	0.2	0.6	0.3	0.4
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	15.3^a	16.1^a	12.6	12.4	11.3
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	9.4^a	10.9^a	7.5^a	7.1	5.1
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	6.9	6.0	5.4	4.4	5.9
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	4.8	6.8	5.8	6.2	5.5
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	4.2	6.0	5.6	5.6	4.8
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.2	1.9	0.8	1.2	1.6
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.8	5.8	5.2	5.3	4.6
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	9.4^a	11.0^a	7.6^a	7.1	5.1
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	22.4^a	20.8	17.9	18.0	18.0
PAST MONTH USE
Alcohol	28.4^a	29.5^a	26.4^a	26.5^a	23.6^a	23.8^a	24.0^a	19.5	21.1	18.6	17.2	17.6	17.9	18.2
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	10.7	9.2	9.7	9.8	9.8
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	2.3	1.8	1.3	0.7^a	1.6
Cigarette Use	21.3^a	20.8^a	18.8^a	19.7^a	16.2^a	16.2^a	14.1^a	11.8^a	10.2^a	10.0^a	8.9^a	7.4^a	7.3^a	4.8
Daily Cigarette Use	6.1^a	5.5^a	3.8^a	3.9^a	3.4^a	4.2^a	2.9^a	1.7^a	2.0^a	2.3^a	0.9	0.8	0.7	0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019.

200406

Table 11.8A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with No Major Depressive Episode in Past Year: Numbers in Thousands, 2004-2019
Substance	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3,251^a	2,823	3,010	2,888	2,926
Marijuana	2,998^a	2,763^a	2,803^a	2,629^a	2,693^a	2,810^a	2,836^a	2,962^a	2,746^a	2,561^a	2,479^a	2,366	2,136	2,283	2,164	2,256
Cocaine	335^a	335^a	337^a	302^a	238^a	196^a	178^a	165^a	123^a	93	115^a	115	91	87	66	67
Crack	44^a	37^a	57^a	45^a	22^a	18^a	9^a	18^a	12	7	5	5	4	14	1	2
Heroin	37	23	26	15	27	25	18	36	20	20	13	14	9	7	5	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	371^a	308	346	254	279
LSD	117^a	108^a	86^a	108^a	150	97^a	103^a	113^a	106^a	108^a	163	177	157	173	136	171
PCP	47^a	64^a	47^a	48^a	40^a	35	26	26	36	20	22	29	12	10	7	14
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	151^a	111	121	80	78
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	457	378^a	418	460	476
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	22	23	31	32	28
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1,044^a	851^a	824^a	767^a	643
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	700^a	556^a	526^a	444^a	358
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	305^a	275	280	231	230
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	315^a	285	313	275	239
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	277	260	282	253	214
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	73^a	50	50	29	34
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	260	250	280	243	212
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	710^a	563^a	526^a	448^a	358
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1,610^a	1,335^a	1,373^a	1,284	1,181
PAST MONTH USE
Alcohol	3,741^a	3,515^a	3,635^a	3,413^a	3,088^a	3,114^a	2,793^a	2,759^a	2,660^a	2,316^a	2,219^a	1,823	1,726	1,862^a	1,618	1,658
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1,127^a	901	990^a	843	837
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	165	132	129	105	146
Cigarette Use	2,420^a	2,221^a	2,214^a	2,047^a	1,858^a	1,825^a	1,659^a	1,557^a	1,294^a	1,042^a	900^a	755^a	574^a	538^a	427	368
Daily Cigarette Use	628^a	568^a	583^a	527^a	417^a	433^a	388^a	349^a	285^a	212^a	229^a	141^a	94^a	68	73	55
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200406

Table 11.8B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with No Major Depressive Episode in Past Year: Percentages, 2004-2019
Substance	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
PAST YEAR USE
Illicit Drugs	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	15.3	13.4^a	14.3	14.0	14.4
Marijuana	13.3^a	12.1^a	12.2^a	11.6	12.0	12.7^a	12.9^a	13.2^a	12.4^a	11.8	11.6	11.1	10.1^a	10.9	10.5	11.1
Cocaine	1.5^a	1.5^a	1.5^a	1.3^a	1.1^a	0.9^a	0.8^a	0.7^a	0.6^a	0.4	0.5	0.5	0.4	0.4	0.3	0.3
Crack	0.2^a	0.2^a	0.2^a	0.2^a	0.1^a	0.1^a	0.0^a	0.1^a	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Heroin	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	*
Hallucinogens	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.7	1.5	1.6	1.2	1.4
LSD	0.5^a	0.5^a	0.4^a	0.5^a	0.7	0.4^a	0.5^a	0.5^a	0.5^a	0.5^a	0.8	0.8	0.7	0.8	0.7	0.8
PCP	0.2^a	0.3^a	0.2^a	0.2^a	0.2^a	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1
Ecstasy	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.7^a	0.5	0.6	0.4	0.4
Inhalants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	2.2	1.8^a	2.0	2.2	2.3
Methamphetamine	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.1	0.1	0.1	0.2	0.1
Misuse of Psychotherapeutics	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	4.9^a	4.0^a	3.9^a	3.7	3.2
Pain Relievers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.3^a	2.6^a	2.5^a	2.2	1.8
Stimulants	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.4	1.3	1.3	1.1	1.1
Tranquilizers or Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.5	1.3	1.5	1.3	1.2
Tranquilizers	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.3	1.2	1.3	1.2	1.1
Sedatives	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.3^a	0.2	0.2	0.1	0.2
Benzodiazepines	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	1.2	1.2	1.3	1.2	1.0
Opioids	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	3.3^a	2.7^a	2.5^a	2.2	1.8
Illicit Drugs Other Than Marijuana¹	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	7.6^a	6.3	6.5	6.2	5.8
PAST MONTH USE
Alcohol	16.5^a	15.4^a	15.8^a	15.0^a	13.8^a	14.1^a	12.8^a	12.3^a	12.0^a	10.7^a	10.3^a	8.6	8.2	8.9	7.8	8.2
Binge Alcohol Use²	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	5.3^a	4.3	4.7	4.1	4.1
Heavy Alcohol Use	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	nc	0.8	0.6	0.6	0.5	0.7
Cigarette Use	10.7^a	9.8^a	9.7^a	9.0^a	8.3^a	8.2^a	7.6^a	7.0^a	5.8^a	4.8^a	4.2^a	3.6^a	2.7^a	2.6^a	2.1	1.8
Daily Cigarette Use	2.8^a	2.5^a	2.5^a	2.3^a	1.9^a	2.0^a	1.8^a	1.6^a	1.3^a	1.0^a	1.1^a	0.7^a	0.4^a	0.3	0.4	0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. ¹ Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Estimates of binge alcohol use include use by those who were heavy alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200415

Table 11.9A – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Numbers in Thousands, 2015-2019
Substance Use Disorder Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER	350	333	345	358	397
Male	87	72	101	114	111
Female	263	261	244	244	286
Illicit Drug Use Disorder	241^a	236^a	260	279	313
Male	57	59	80	87	92
Female	184	177	180	193	221
Alcohol Use Disorder	202	182	164	159	176
Male	51	27	47	*	*
Female	151	156	118	108	123
NO SUBSTANCE USE DISORDER	2,681^a	2,756^a	2,869^a	3,124^a	3,386
Male	638^a	714^a	744^a	832^a	965
Female	2,043^a	2,042^a	2,125^a	2,292	2,421
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.9B – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Percentages, 2015-2019
Substance Use Disorder Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER	29.1^a	33.0	35.9	40.6	36.8
Male	14.8^a	15.0^a	22.6	26.4	22.4
Female	42.8	49.5	47.6	54.4	49.0
Illicit Drug Use Disorder	28.9^a	31.8	36.2	42.8	36.3
Male	13.7^a	15.4	22.7	25.9	22.0
Female	43.9	49.0	49.1	60.5	49.6
Alcohol Use Disorder	33.0^a	39.5	38.5	40.8	44.0
Male	17.4	14.6	26.7	*	*
Female	47.0	55.8	46.8	48.1	51.3
NO SUBSTANCE USE DISORDER	11.6^a	11.9^a	12.3^a	13.4^a	14.8
Male	5.4^a	6.0^a	6.2^a	7.0^a	8.2
Female	18.2^a	18.0^a	18.7^a	20.2	21.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.10A – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Numbers in Thousands, 2015-2019
Substance Use Disorder Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER	303	278	276	288	332
Male	70	56^a	81	82	94
Female	232	222	195	207	238
Illicit Drug Use Disorder	219	202	215	227	258
Male	48	44	66	60	76
Female	172	158	149	167	182
Alcohol Use Disorder	172	152	124	132	151
Male	43	22	34	*	*
Female	129	130	90	93	107
NO SUBSTANCE USE DISORDER	1,826^a	1,890^a	1,989^a	2,135^a	2,340
Male	407^a	483^a	500^a	546	642
Female	1,419^a	1,407^a	1,489^a	1,588	1,697
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.10B – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Percentages, 2015-2019
Substance Use Disorder Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER	25.2	27.5	28.8	32.7	30.7
Male	12.0^a	11.6^a	18.1	18.9	18.9
Female	37.8	42.2	38.1	46.0	40.8
Illicit Drug Use Disorder	26.3	27.3	29.9	34.8	30.0
Male	11.5	11.7	18.8	18.0	18.3
Female	40.9	43.6	40.6	52.4^a	41.1
Alcohol Use Disorder	28.2	32.8	29.1	33.9	37.7
Male	14.7	11.9	19.6	*	*
Female	40.2	46.5	35.7	41.3	44.8
NO SUBSTANCE USE DISORDER	7.9^a	8.2^a	8.5^a	9.2^a	10.2
Male	3.4^a	4.1^a	4.2^a	4.6^a	5.5
Female	12.6^a	12.4^a	13.1^a	14.0	15.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200505

Table 11.11A – Substance Use Disorder, Illicit Drug Use Disorder, and Alcohol Use Disorder in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Gender: Numbers in Thousands, 2015-2019
Substance Use Disorder/ MDE Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER
MDE	350	333	345	358	397
Male	87	72	101	114	111
Female	263	261	244	244	286
MDE WITH SEVERE IMPAIRMENT	303	278	276	288	332
Male	70	56^a	81	82	94
Female	232	222	195	207	238
NO MDE	854^a	676	615	523^a	682
Male	502^a	411	346	318	385
Female	352	265	268	205^a	298
ILLICIT DRUG USE DISORDER
MDE	241^a	236^a	260	279	313
Male	57	59	80	87	92
Female	184	177	180	193	221
MDE WITH SEVERE IMPAIRMENT	219	202	215	227	258
Male	48	44	66	60	76
Female	172	158	149	167	182
NO MDE	593	506	459	374^a	549
Male	357	321	272	248^a	325
Female	235	185	186	126^a	224
ALCOHOL USE DISORDER
MDE	202	182	164	159	176
Male	51	27	47	50	53
Female	151	156	118	108	123
MDE WITH SEVERE IMPAIRMENT	172	152	124	132	151
Male	43	22	34	39	43
Female	129	130	90	93	107
NO MDE	411^a	279	262	231	224
Male	240^a	156^a	129	114	107
Female	171^a	123	134	117	117
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200505

Table 11.11B – Substance Use Disorder, Illicit Drug Use Disorder, and Alcohol Use Disorder in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Gender: Percentages, 2015-2019
Substance Use Disorder/ MDE Status/Gender	2015	2016	2017	2018	2019
SUBSTANCE USE DISORDER
MDE	11.6	10.8	10.7	10.3	10.5
Male	12.0	9.2	12.0	12.0	10.3
Female	11.4	11.3	10.3	9.6	10.6
MDE WITH SEVERE IMPAIRMENT	14.2	12.8	12.2	11.9	12.4
Male	14.7	10.4	13.9	13.0	12.7
Female	14.1	13.6	11.6	11.5	12.3
NO MDE	4.0^a	3.2	2.9	2.5^a	3.4
Male	4.3^a	3.6	3.0	2.8	3.4
Female	3.7	2.8	2.8	2.2^a	3.3
ILLICIT DRUG USE DISORDER
MDE	8.0	7.6	8.1	8.0	8.3
Male	7.8	7.5	9.5	9.2	8.5
Female	8.0	7.7	7.6	7.6	8.1
MDE WITH SEVERE IMPAIRMENT	10.3	9.3	9.5	9.4	9.7
Male	10.0	8.2	11.4	9.6	10.4
Female	10.4	9.7	8.8	9.3	9.4
NO MDE	2.8	2.4	2.2^a	1.8^a	2.7
Male	3.1	2.8	2.4	2.2^a	2.9
Female	2.5	1.9	2.0	1.4^a	2.5
ALCOHOL USE DISORDER
MDE	6.7^a	5.9	5.1	4.6	4.6
Male	7.0	3.4	5.5	5.3	4.9
Female	6.6	6.8^a	5.0	4.3	4.5
MDE WITH SEVERE IMPAIRMENT	8.1^a	7.0	5.5	5.5	5.6
Male	8.9	4.0	5.9	6.2	5.9
Female	7.8	8.0	5.3	5.2	5.5
NO MDE	1.9^a	1.3	1.2	1.1	1.1
Male	2.1^a	1.4	1.1	1.0	1.0
Female	1.8	1.3	1.4	1.3	1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.12A – Co-Occurring Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Gender: Numbers in Thousands, 2015-2019
Substance Use Disorder (SUD), Illicit Drug Use Disorder (IDUD), or Alcohol Use Disorder (AUD) and MDE/Gender	2015	2016	2017	2018	2019
SUD and MDE	350	333	345	358	397
Male	87	72	101	114	111
Female	263	261	244	244	286
SUD and MDE with Severe Impairment	303	278	276	288	332
Male	70	56^a	81	82	94
Female	232	222	195	207	238
IDUD and MDE	241^a	236^a	260	279	313
Male	57	59	80	87	92
Female	184	177	180	193	221
IDUD and MDE with Severe Impairment	219	202	215	227	258
Male	48	44	66	60	76
Female	172	158	149	167	182
AUD and MDE	202	182	164	159	176
Male	51	27	47	50	53
Female	151	156	118	108	123
AUD and MDE with Severe Impairment	172	152	124	132	151
Male	43	22	34	39	43
Female	129	130	90	93	107
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.12B – Co-Occurring Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Gender: Percentages, 2015-2019
Substance Use Disorder (SUD), Illicit Drug Use Disorder (IDUD), or Alcohol Use Disorder (AUD) and MDE/Gender	2015	2016	2017	2018	2019
SUD and MDE	1.4	1.4	1.4	1.5	1.7
Male	0.7	0.6	0.8	0.9	0.9
Female	2.2	2.2	2.1	2.1	2.4
SUD and MDE with Severe Impairment	1.2	1.1	1.1	1.2	1.4
Male	0.6	0.5^a	0.7	0.7	0.8
Female	2.0	1.9	1.6	1.8	2.0
IDUD and MDE	1.0^a	1.0^a	1.1	1.2	1.3
Male	0.5	0.5	0.6	0.7	0.7
Female	1.6	1.5	1.5	1.6	1.9
IDUD and MDE with Severe Impairment	0.9	0.8	0.9	0.9	1.1
Male	0.4	0.4^a	0.5	0.5	0.6
Female	1.4	1.3	1.3	1.4	1.6
AUD and MDE	0.8	0.8	0.7	0.7	0.7
Male	0.4	0.2	0.4	0.4	0.4
Female	1.3	1.3	1.0	0.9	1.0
AUD and MDE with Severe Impairment	0.7	0.6	0.5	0.5	0.6
Male	0.3	0.2	0.3	0.3	0.4
Female	1.1	1.1	0.8	0.8	0.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.13A – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Numbers in Thousands, 2004-2019
MDE/Type of Treatment	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
MDE
Saw or Talked to a Health Professional OR Used Prescription Medication	856^a	778^a	700^a	739^a	731^a	638^a	682^a	724^a	791^a	944^a	1,076^a	1,139^a	1,223^a	1,286^a	1,371^a	1,577
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication	425^a	404^a	407^a	372^a	406^a	358^a	370^a	397^a	431^a	522^a	543^a	596^a	571^a	625^a	749	796
Used Prescription Medication BUT Did Not See or Talk to a Health Professional	76^a	58^a	47^a	53^a	60^a	46^a	58^a	52^a	52^a	94	75^a	87	59^a	76^a	77^a	127
Saw or Talked to a Health Professional AND Used Prescription Medication	342^a	308^a	241^a	307^a	259^a	231^a	252^a	272^a	302^a	316^a	447^a	447^a	576	570	533^a	645
MDE with Severe Impairment
Saw or Talked to a Health Professional OR Used Prescription Medication	--	--	575^a	574^a	598^a	515^a	528^a	570^a	618^a	808^a	851^a	924^a	986^a	1,044^a	1,094^a	1,287
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication	--	--	314^a	281^a	313^a	283^a	280^a	303^a	309^a	421^a	423^a	468^a	413^a	477^a	575	622
Used Prescription Medication BUT Did Not See or Talk to a Health Professional	--	--	37^a	39^a	49^a	37^a	34^a	33^a	43^a	86	63	66	48^a	54^a	55^a	99
Saw or Talked to a Health Professional AND Used Prescription Medication	--	--	220^a	249^a	232^a	191^a	212^a	232^a	260^a	287^a	360^a	386^a	513	505	455^a	560
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200415

Table 11.13B – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Percentages, 2004-2019
MDE/Type of Treatment	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
MDE
Saw or Talked to a Health Professional OR Used Prescription Medication	38.7	35.9^a	35.9^a	37.0^a	36.3^a	33.0^a	35.8^a	36.3^a	36.0^a	36.9^a	39.6	37.9^a	40.2	40.3	40.0	42.2
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication	19.3	18.6	20.9	18.6	20.2	18.5	19.4	19.9	19.6	20.4	20.0	19.8	18.8	19.6	21.8	21.3
Used Prescription Medication BUT Did Not See or Talk to a Health Professional	3.4	2.7	2.4	2.7	3.0	2.4	3.0	2.6	2.4	3.7	2.8	2.9	1.9^a	2.4	2.2	3.4
Saw or Talked to a Health Professional AND Used Prescription Medication	15.5	14.1^a	12.3^a	15.3	12.8^a	11.9^a	13.2^a	13.6^a	13.7^a	12.3^a	16.4	14.8	18.9	17.9	15.4	17.1
MDE with Severe Impairment
Saw or Talked to a Health Professional OR Used Prescription Medication	--	--	42.9^a	42.1^a	41.1^a	37.0^a	39.3^a	41.3^a	40.2^a	43.8^a	43.2^a	43.7^a	46.1	46.2	45.5	48.7
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication	--	--	23.4	20.6	21.5	20.3	20.8	21.9	20.1	22.9	21.5	22.1	19.3^a	21.1	24.0	23.5
Used Prescription Medication BUT Did Not See or Talk to a Health Professional	--	--	2.7	2.9	3.3	2.7	2.5	2.4	2.8	4.7	3.2	3.1	2.3	2.4	2.3	3.7
Saw or Talked to a Health Professional AND Used Prescription Medication	--	--	16.4^a	18.3	15.9^a	13.7^a	15.7^a	16.7^a	16.9^a	15.6^a	18.2	18.2	24.0	22.4	18.9	21.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2019 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019.

200415

Table 11.14A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status: Numbers in Thousands, 2015-2019
Substance Use Disorder (SUD) Status/MDE Status/Receipt of Substance Use Treatment (SU Tx) and Mental Health (MH) Services	2015	2016	2017	2018	2019
SUD and MDE
Received SU Tx at a Specialty Facility OR MH Services	221	239	216	234	263
Received SU Tx at a Specialty Facility BUT NOT MH Services	*	5	*	3	10
Received MH Services BUT NOT SU Tx at a Specialty Facility	208	219	195	211	249
Received SU Tx at a Specialty Facility AND MH Services	13	15	20^a	19^a	5
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	129	94	128	122	134
SUD and MDE with Severe Impairment
Received SU Tx at a Specialty Facility OR MH Services	202	208	181	206	225
Received SU Tx at a Specialty Facility BUT NOT MH Services	*	5	*	3	*
Received MH Services BUT NOT SU Tx at a Specialty Facility	189	188	160	190	214
Received SU Tx at a Specialty Facility AND MH Services	13	15	20^a	13	5
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	101	70	95	80	106
SUD and No MDE
Received SU Tx at a Specialty Facility OR MH Services	277	249	227	173	229
Received SU Tx at a Specialty Facility BUT NOT MH Services	12	23	8	12	11
Received MH Services BUT NOT SU Tx at a Specialty Facility	245	205	198	145	198
Received SU Tx at a Specialty Facility AND MH Services	20	21	20	15	19
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	563^a	422	379	338^a	442
MDE and No SUD
Received SU Tx at a Specialty Facility OR MH Services	1,283^a	1,440^a	1,551^a	1,550^a	1,786
Received SU Tx at a Specialty Facility BUT NOT MH Services	0	0	*	*	1
Received MH Services BUT NOT SU Tx at a Specialty Facility	1,276^a	1,439^a	1,544^a	1,547^a	1,784
Received SU Tx at a Specialty Facility AND MH Services	7	1	7	3	1
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	1,389^a	1,297^a	1,288^a	1,561	1,571
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.

200415

Table 11.14B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status: Percentages, 2015-2019
Substance Use Disorder (SUD) Status/MDE Status/Receipt of Substance Use Treatment (SU Tx) and Mental Health (MH) Services	2015	2016	2017	2018	2019
SUD and MDE
Received SU Tx at a Specialty Facility OR MH Services	63.1	71.9	62.7	65.7	66.3
Received SU Tx at a Specialty Facility BUT NOT MH Services	*	1.5	*	0.8	2.4
Received MH Services BUT NOT SU Tx at a Specialty Facility	59.4	65.8	56.8	59.5	62.5
Received SU Tx at a Specialty Facility AND MH Services	3.8	4.6^a	5.9^a	5.4^a	1.3
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	36.9	28.1	37.3	34.3	33.7
SUD and MDE with Severe Impairment
Received SU Tx at a Specialty Facility OR MH Services	66.7	74.8	65.6	72.1	68.0
Received SU Tx at a Specialty Facility BUT NOT MH Services	*	1.8	*	1.0	*
Received MH Services BUT NOT SU Tx at a Specialty Facility	62.4	67.5	58.2	66.4	64.4
Received SU Tx at a Specialty Facility AND MH Services	4.3	5.5^a	7.4^a	4.7	1.6
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	33.3	25.2	34.4	27.9	32.0
SUD and No MDE
Received SU Tx at a Specialty Facility OR MH Services	33.0	37.1	37.4	33.8	34.1
Received SU Tx at a Specialty Facility BUT NOT MH Services	1.3	3.5	1.2	2.4	1.5
Received MH Services BUT NOT SU Tx at a Specialty Facility	29.2	30.5	32.7	28.4	29.5
Received SU Tx at a Specialty Facility AND MH Services	2.4	3.1	3.3	2.8	2.8
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	67.0	62.9	62.6	66.2	65.9
MDE and No SUD
Received SU Tx at a Specialty Facility OR MH Services	48.0^a	52.6	54.6	49.8	53.2
Received SU Tx at a Specialty Facility BUT NOT MH Services	0.0	0.0	*	*	0.0
Received MH Services BUT NOT SU Tx at a Specialty Facility	47.7^a	52.6	54.4	49.7	53.1
Received SU Tx at a Specialty Facility AND MH Services	0.3	0.0	0.2	0.1	0.0
Received NEITHER SU Tx at a Specialty Facility NOR MH Services	52.0^a	47.4	45.4	50.2	46.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. ^a The difference between this estimate and the 2019 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2019.